Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancer-Reference-Cited by-同舟云学术

Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancer

Published:2019-01-22 Issue:6 Volume:120 Page:10787-10795
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Hassani Mahmoud¹^ORCID,Hajari Taheri Fatemeh²,Sharifzadeh Zahra²,Arashkia Arash³,Hadjati Jamshid⁴,van Weerden Wytske M.⁵,Modarressi Mohammad Hossein¹,Abolhassani Mohsen²

Affiliation:

1. Department of Molecular Medicine School of Advanced Technologies in Medicine, Tehran University of Medical Sciences Tehran Iran

2. Department of Immunology Hybridoma Lab, Pasteur Institute of Iran Tehran Iran

3. Department of Virology Pasteur Institute of Iran Tehran Iran

4. Department of Immunology School of Medicine, Tehran University of Medical Sciences Tehran Iran

5. Department of Urology Erasmus Medical Center Rotterdam The Netherlands

Funder

Tehran University of Medical Sciences and Health Services

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.28370

Reference40 articles.

1. Prostate cancer

2. Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma

3. Adoptive immunotherapy for cancer: harnessing the T cell response

4. Treating cancer with genetically engineered T cells

5. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients;Horoszewicz JS;Anticancer Res,1987

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates on allogeneic CAR-T cells in hematological malignancies;Cancer Cell International;2024-09-03

2. Progress in the Utilization of Nanobody CAR-T Cell in Cancer Immunotherapy;Journal of Biomedical Nanotechnology;2024-08-01

3. CAR-T cell-derived exosomes: a new perspective for cancer therapy;Stem Cell Research & Therapy;2024-06-18

4. Tuning spacer length improves the functionality of the nanobody-based VEGFR2 CAR T cell;BMC Biotechnology;2024-01-04

5. Chimeric antigen receptor-modified T cells therapy in prostate cancer: A comprehensive review on the current state and prospects;Heliyon;2023-08